| Sep 19 |
Abbott a new overweight at Piper Sandler; at attractive entry point
|
| Sep 19 |
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
|
| Sep 19 |
Piper Sandler initiates Abbott Laboratories with "overweight" rating, $131 PT
|
| Sep 19 |
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
|
| Sep 19 |
Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market?
|
| Sep 19 |
Jim Cramer on Microsoft Corporation (MSFT): ‘You’ve Hit On One Of The Top Five Stocks In This Entire Market’
|
| Sep 19 |
Jim Cramer on Apple Inc. (AAPL): ‘The Weekend’s Pre-orders For The New iPhone 16 Were Anemic’ According to Firms
|
| Sep 19 |
Jim Cramer Says NVIDIA Corporation (NVDA)’s ‘Doing Better Than Ever’
|
| Sep 19 |
Jim Cramer Says Broadcom Inc. (AVGO) ‘Has Been A Wild Trader These Last Few Weeks’
|
| Sep 19 |
Jim Cramer on Lam Research Corporation (LRCX): ‘I Think Lam Is Dramatically Oversold’
|
